肺癌疫苗应用现状与研制展望(5)
15.Arlen P, Tsang KY, Marshall JL, et al. The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines. Cancer Immunol Immunother. 2000 Dec;49(10):517-29.
16.Morse MA. Technology evaluation: BLP-25, Biomira Inc. Curr Opin Mol Ther. 2001 Feb;3(1):102-5.
17.Hodge JW, Schlom J. Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines. Cancer Res. 1999 Oct 15;59(20):5106-11.
18.吴一龙主编。肺癌多学科综合治疗的理论与实践。人民卫生出版社，142-143.
19.Cappello S, Liu NX, Musselli C, et al. Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells. Cancer Immunol Immunother. 1999 Dec;48(9):483-92.
20.Klein C, Bueler H, Mulligan RC. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. J Exp Med. 2000 May 15;191(10):1699-708.
21.el-Shami KM, Tzehoval E, Vadai E, et al. Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines. J Interferon Cytokine Res. 1999 Dec;19(12):1391-401.
22.Wittig B, Marten A, Dorbic T, et al. Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial. Hum Gene Ther. 2001 Feb 10;12(3):267-78., 百拇医药(黄邵洪，钟文昭，吴一龙，谷力加，翁毅敏，冯卫能，程超)
16.Morse MA. Technology evaluation: BLP-25, Biomira Inc. Curr Opin Mol Ther. 2001 Feb;3(1):102-5.
17.Hodge JW, Schlom J. Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines. Cancer Res. 1999 Oct 15;59(20):5106-11.
18.吴一龙主编。肺癌多学科综合治疗的理论与实践。人民卫生出版社，142-143.
19.Cappello S, Liu NX, Musselli C, et al. Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells. Cancer Immunol Immunother. 1999 Dec;48(9):483-92.
20.Klein C, Bueler H, Mulligan RC. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. J Exp Med. 2000 May 15;191(10):1699-708.
21.el-Shami KM, Tzehoval E, Vadai E, et al. Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines. J Interferon Cytokine Res. 1999 Dec;19(12):1391-401.
22.Wittig B, Marten A, Dorbic T, et al. Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial. Hum Gene Ther. 2001 Feb 10;12(3):267-78., 百拇医药(黄邵洪，钟文昭，吴一龙，谷力加，翁毅敏，冯卫能，程超)